Joe Paul Mampilly
About Joe Paul Mampilly
Data last updated:
Joe Paul Mampilly is a Director at Pure Em Life Science India Private Limited (since 2022). The company operates in Pharma. Pure Em Life Science India Private Limited reported revenue of ₹8.43 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pure Em Life Science India Private Limited U33309KL2019PTC058947 | Director | 01 Apr 2022 | 2019 | ₹8.43 Cr (FY 2025) | Active |
Board colleagues of Joe Paul Mampilly
| Name | DIN | Company | Designation |
|---|---|---|---|
| Fazil Salam | 08518710 | Pure Em Life Science India Private Limited | Managing Director |
| Geemon Kadianthuruthil Korah | 02099905 | Pure Em Life Science India Private Limited | Director |
| Sam Babu | 07598031 | Pure Em Life Science India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Joe Paul Mampilly
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Joe Paul Mampilly
Joe Paul Mampilly currently holds 1 directorship: Pure Em Life Science India Private Limited (Director, since 01 Apr 2022, revenue ₹8.43 Cr (FY 2025)).
Joe Paul Mampilly was first appointed on 01 Apr 2022 as Director at Pure Em Life Science India Private Limited.
The current boards of Joe Paul Mampilly's companies include Fazil Salam (Pure Em Life Science India Private Limited), Geemon Kadianthuruthil Korah (Pure Em Life Science India Private Limited), Sam Babu (Pure Em Life Science India Private Limited).